UY39600A - Inhibidores del receptor del factor de crecimiento epidérmico - Google Patents

Inhibidores del receptor del factor de crecimiento epidérmico

Info

Publication number
UY39600A
UY39600A UY0001039600A UY39600A UY39600A UY 39600 A UY39600 A UY 39600A UY 0001039600 A UY0001039600 A UY 0001039600A UY 39600 A UY39600 A UY 39600A UY 39600 A UY39600 A UY 39600A
Authority
UY
Uruguay
Prior art keywords
growth factor
factor receptor
epidermal growth
receptor inhibitors
compounds
Prior art date
Application number
UY0001039600A
Other languages
English (en)
Inventor
Dmitry Valentinovich Morozov
Kirill Vadimovich Zavialov
Artsiom Evgenievich Shekhautsou
Ilia Alexeevich Smetanin
Georgii Viktorovich Iakobson
Shamil Dinarovich Kadyrov
Adel Ravilevich Khaidarov
Daria Dmitrievna Beketova
Daniel Evgenevich Polianczyk
Ramilia Rinadovna Starodubtseva
Polina Olegovna Suntsova
Dmitry Alekseevich Khalabudin
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2021137120A external-priority patent/RU2021137120A/ru
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of UY39600A publication Critical patent/UY39600A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a nuevos compuestos de la fórmula I o sal, solvato o estereoisómero farmacéuticamente aceptables de los mismos, que tienen propiedades inhibidoras del EGFR, a las composiciones farmacéuticas que contienen dichos compuestos, a los métodos de tratamiento de enfermedades o trastornos y al uso de dichos compuestos como productos farmacéuticos para tratar enfermedades o trastornos.
UY0001039600A 2020-12-30 2021-12-30 Inhibidores del receptor del factor de crecimiento epidérmico UY39600A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2020144141 2020-12-30
RU2021137120A RU2021137120A (ru) 2021-12-15 Ингибиторы рецептора эпидермального фактора роста

Publications (1)

Publication Number Publication Date
UY39600A true UY39600A (es) 2022-05-31

Family

ID=82259596

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001039600A UY39600A (es) 2020-12-30 2021-12-30 Inhibidores del receptor del factor de crecimiento epidérmico

Country Status (3)

Country Link
TW (1) TW202241890A (es)
UY (1) UY39600A (es)
WO (1) WO2022146201A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110207736A1 (en) * 2009-12-23 2011-08-25 Gatekeeper Pharmaceuticals, Inc. Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
US20130137709A1 (en) * 2010-05-05 2013-05-30 Nathanael S. Gray Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith
CN104140418B (zh) * 2014-08-15 2016-08-24 常州润诺生物科技有限公司 2-(2，4，5-取代苯胺)嘧啶衍生物及其用途
RU2702631C2 (ru) * 2014-10-11 2019-10-09 Шанхай Хэнсох Биомедикал Ко., Лтд. Ингибитор egfr и его получение и применение

Also Published As

Publication number Publication date
WO2022146201A1 (en) 2022-07-07
TW202241890A (zh) 2022-11-01

Similar Documents

Publication Publication Date Title
CL2020001097A1 (es) Derivados de piridincarbonilo y usos terapéuticos de los mismos como inhibidores de trpc6.
CO2019007810A2 (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
CL2018001145A1 (es) Compuestos inhibidores de jak quinasa para el tratamiento de enfermedad respiratoria
CO2020015758A2 (es) Compuestos de purinona y su uso en el tratamiento del cáncer
EA201792214A1 (ru) Соединения замещенного хиназолина
EA201790122A1 (ru) Производные 2-h-индазола в качестве ингибиторов циклинзависимых киназ (cdk) и их терапевтическое применение
BR112021007788A8 (pt) Composto inibidor de jak 2-azabiciclo hexano
CY1124243T1 (el) Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1
CU20190080A7 (es) Derivados de isoindolina útiles para tratar la esteatohepatitis no alcohólica y otras enfermedades de curación disfuncional del tejido y fibrosis
UA109698C2 (xx) Похідні азаіндазолу або діазаіндазолу як медикамент
CO2021002976A2 (es) Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak
DOP2021000198A (es) Compuestos y su uso en el tratamiento del cáncer
ECSP14007965A (es) Formulaciones de (+)-2-[1-(3-etoxi-4-metoxi-fenil)-2-metansulfonil-etil]-4-acetil aminoisoindolin-1, 3-diona
DOP2016000308A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
DOP2013000314A (es) Composición farmacéutica oftalmológica tópica que contiene regorafenib
BR112021011325A2 (pt) Derivados de rapamicina
CL2022002975A1 (es) Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso
MX2020004025A (es) Inhibidor del receptor del factor de crecimiento epidermico.
CY1120608T1 (el) Φαρμακευτικως δραστικες ενωσεις
BR112017021583A2 (pt) métodos para o tratamento de transtornos inflamatórios
CO2021001174A2 (es) Inhibidores de ckd8/19
BR112018073419A2 (pt) combinação, uso da combinação, método para o tratamento, composto, método para o tratamento de doença de alzheimer e composição farmacêutica
UY39600A (es) Inhibidores del receptor del factor de crecimiento epidérmico
BR112022016124A2 (pt) Composto de di-hidronaftiridinona, e método de preparação para este e uso médico deste
UY38133A (es) Nuevos inhibidores de cdk8/19